The present invention relates to methods for predicting the survival time of patients from endometrial adenocarcinoma. The present invention also relates to methods and pharmaceutical compositions for the treatment of endometrial adenocarcinoma.FORGEZ Patricia...
Treatment and prognosis of patients with stage II endometrial carcinomadoi:10.1016/0360-3016(77)90536-3International Journal of Radiation Oncology*Biology*PhysicsF.R. Zivnuska and C.A. Perez and H. Madoc-Jones and A. Galakatos and F. Askin...
A subtype of endometrial adenocarcinomas, adenosquamous carcinoma, includes squamous cells (that is, the type of cells found on the outer surfaces such as the skin or the outermost layer of cells on the uterine cervix). Other subtypes of endometrial adenocarcinomas are papillary serous adenocarcinomas...
cancer diagnosis, prognosis and treatment selection. We focus on DL applications for omics and histopathological data, as well as the integration of multiple data types. We provide a brief introduction to emerging DL methods relevant to applications covered in this review. Next, we discuss specific ...
Risk of endometrial polyps, hyperplasia, carcinoma, and uterine cancer after tamoxifen treatment in premenopausal women with breast cancer. JAMA Netw Open. 2022;5(11): e2243951. https://doi.org/10.1001/jamanetworkopen.2022.43951. (PMID:36441547;PMCID:PMC9706361). Article PubMed PubMed Central ...
Endometrial carcinomalocally advancedirradiationcombined surgery and radiationThe impact of treatment on survival was analyzed in 106 patients with carcinoma of the endometrium stage II (n=61) and stage III (n=45). There was no significant difference in survival in patients with stage II who were ...
Type 2 endometrial cancersare more aggressive. These include rarer subtypes, such as serous, clear cell, mucinous, undifferentiated and dedifferentiated carcinomas. They tend to grow faster and are more likely to spread outside the uterus by the time they are diagnosed. These cancers do not look...
Abstract A retrospective analysis of causes of death in 398 patients with endometrial carcinoma and sites of treatment failure in 105 cases, all seen at the University of Michigan Medical Center between 1930 and 1971, is the subject of this report. Of 398 patients (337 with Stage I, 61 with...
When it comes to ER expression, ER + breast cancer has unique clinicopathological characteristics, including older age, smaller size, lower grade, and a better prognosis [113, 114]. Similarly, it was discovered that well-differentiated breast carcinomas have higher levels of ER expression ...
EP: 1.Overview of Cutaneous Squamous Cell Carcinoma and Melanoma EP: 2.Unmet Needs and Prognosis for CSCC and Melanoma EP: 3.Multidisciplinary Management of CSCC EP: 4.Choosing Systemic Therapies for Patients with Unresectable or Metastatic CSCC Now Viewing EP: 5.CSCC Treatment Options: Cemiplim...